<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5A8E328E-8A10-45F8-9C51-6BD66C215CC0"><gtr:id>5A8E328E-8A10-45F8-9C51-6BD66C215CC0</gtr:id><gtr:name>Nottingham University Hospital NHS Trust</gtr:name><gtr:address><gtr:line1>Nottingham University HospitalMedical Physics and clinical engineeringQMC Campus</gtr:line1><gtr:city>Nottingham</gtr:city><gtr:postCode>NG7 2UH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/62C544E8-A6D5-4B0C-9773-7A30B21F968D"><gtr:id>62C544E8-A6D5-4B0C-9773-7A30B21F968D</gtr:id><gtr:name>University of Padua</gtr:name><gtr:address><gtr:line1>Universita di Padova</gtr:line1><gtr:line4>Padova</gtr:line4><gtr:postCode>35129</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F0678985-3705-4E70-9B10-6E3ECB46F12F"><gtr:id>F0678985-3705-4E70-9B10-6E3ECB46F12F</gtr:id><gtr:name>European Molecular Biology Laboratory (EMBL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E5A82D2C-5AD4-488A-ACFF-566345A5D6DA"><gtr:id>E5A82D2C-5AD4-488A-ACFF-566345A5D6DA</gtr:id><gtr:name>Heriot-Watt University</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Riccarton</gtr:line2><gtr:line3>Ricarton</gtr:line3><gtr:line4>Currie</gtr:line4><gtr:postCode>EH14 4AS</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FBA6B196-26E4-43B2-894C-8257F77FE7A0"><gtr:id>FBA6B196-26E4-43B2-894C-8257F77FE7A0</gtr:id><gtr:name>University of North Carolina</gtr:name><gtr:address><gtr:line1>Chapel Hill</gtr:line1><gtr:postCode>NC 27599</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/75F9149D-26D1-48A2-9A4F-FCF033A4766A"><gtr:id>75F9149D-26D1-48A2-9A4F-FCF033A4766A</gtr:id><gtr:name>University of Kassel</gtr:name><gtr:address><gtr:line1>Kassel University</gtr:line1><gtr:line4>Witzenhausen</gtr:line4><gtr:postCode>D-37213</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C"><gtr:id>FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C</gtr:id><gtr:name>University of Alabama at Birmingham</gtr:name><gtr:address><gtr:line1>1720 2nd Avenue South</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:line5>Alabama 35294-0017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/621CACAB-53EE-48C8-A5EF-69DA4FA58943"><gtr:id>621CACAB-53EE-48C8-A5EF-69DA4FA58943</gtr:id><gtr:name>Leibniz Association</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>College of Medical, Veterinary &amp;Life Sci</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E30B7145-0051-47F4-B2D6-C93EE14B8568"><gtr:id>E30B7145-0051-47F4-B2D6-C93EE14B8568</gtr:id><gtr:name>University of Oslo</gtr:name><gtr:address><gtr:line1>Boks 1072 Blindern</gtr:line1><gtr:line4>Oslo</gtr:line4><gtr:line5>NO 0316</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Norway</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5A8E328E-8A10-45F8-9C51-6BD66C215CC0"><gtr:id>5A8E328E-8A10-45F8-9C51-6BD66C215CC0</gtr:id><gtr:name>Nottingham University Hospital NHS Trust</gtr:name><gtr:address><gtr:line1>Nottingham University HospitalMedical Physics and clinical engineeringQMC Campus</gtr:line1><gtr:city>Nottingham</gtr:city><gtr:postCode>NG7 2UH</gtr:postCode><gtr:region>East Midlands</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/62C544E8-A6D5-4B0C-9773-7A30B21F968D"><gtr:id>62C544E8-A6D5-4B0C-9773-7A30B21F968D</gtr:id><gtr:name>University of Padua</gtr:name><gtr:address><gtr:line1>Universita di Padova</gtr:line1><gtr:line4>Padova</gtr:line4><gtr:postCode>35129</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Italy</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F0678985-3705-4E70-9B10-6E3ECB46F12F"><gtr:id>F0678985-3705-4E70-9B10-6E3ECB46F12F</gtr:id><gtr:name>European Molecular Biology Laboratory (EMBL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/4D643118-D00D-43C5-A6C4-6035292F169C"><gtr:id>4D643118-D00D-43C5-A6C4-6035292F169C</gtr:id><gtr:name>Novartis</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E5A82D2C-5AD4-488A-ACFF-566345A5D6DA"><gtr:id>E5A82D2C-5AD4-488A-ACFF-566345A5D6DA</gtr:id><gtr:name>Heriot-Watt University</gtr:name><gtr:address><gtr:line1>Administration Building</gtr:line1><gtr:line2>Riccarton</gtr:line2><gtr:line3>Ricarton</gtr:line3><gtr:line4>Currie</gtr:line4><gtr:postCode>EH14 4AS</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FBA6B196-26E4-43B2-894C-8257F77FE7A0"><gtr:id>FBA6B196-26E4-43B2-894C-8257F77FE7A0</gtr:id><gtr:name>University of North Carolina</gtr:name><gtr:address><gtr:line1>Chapel Hill</gtr:line1><gtr:postCode>NC 27599</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1354C618-9C7F-4E90-97AE-2A04B4C8536D"><gtr:id>1354C618-9C7F-4E90-97AE-2A04B4C8536D</gtr:id><gtr:name>Cancer Research UK (CRUK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/75F9149D-26D1-48A2-9A4F-FCF033A4766A"><gtr:id>75F9149D-26D1-48A2-9A4F-FCF033A4766A</gtr:id><gtr:name>University of Kassel</gtr:name><gtr:address><gtr:line1>Kassel University</gtr:line1><gtr:line4>Witzenhausen</gtr:line4><gtr:postCode>D-37213</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C"><gtr:id>FC9ED2E5-3AE9-4CB4-AD0C-B8953F01D45C</gtr:id><gtr:name>University of Alabama at Birmingham</gtr:name><gtr:address><gtr:line1>1720 2nd Avenue South</gtr:line1><gtr:line4>Birmingham</gtr:line4><gtr:line5>Alabama 35294-0017</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/621CACAB-53EE-48C8-A5EF-69DA4FA58943"><gtr:id>621CACAB-53EE-48C8-A5EF-69DA4FA58943</gtr:id><gtr:name>Leibniz Association</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5A1E6D8C-5EBC-43B9-9D6B-8EE996C05589"><gtr:id>5A1E6D8C-5EBC-43B9-9D6B-8EE996C05589</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Yarwood</gtr:surname><gtr:orcidId>0000-0001-9489-9253</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/599807B2-C178-45E6-8C5F-7A6617273BD5"><gtr:id>599807B2-C178-45E6-8C5F-7A6617273BD5</gtr:id><gtr:firstName>Miles</gtr:firstName><gtr:otherNames>Douglas</gtr:otherNames><gtr:surname>Houslay</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G8604010"><gtr:id>D3D90D55-531A-4286-B132-A7D26FE72967</gtr:id><gtr:title>PDE4 cAMP phosphodiesterases: intracellular targeting and regulation by phosphorylation.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G8604010</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1987-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>5296229</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Novel PDE4 isoforms</gtr:description><gtr:id>F9635CB3-7BA6-414B-A7CB-5022DFCAC9F3</gtr:id><gtr:impact>Joint publications 15025561 15738310</gtr:impact><gtr:partnerContribution>Bio-informatics analyses</gtr:partnerContribution><gtr:piContribution>PDE4 biology expertise and enzymology expertise</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Nottingham University Hospitals NHS Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Queen's Medical Centre</gtr:department><gtr:description>PDE4D5 promoter</gtr:description><gtr:id>26CBEBF8-3608-41AF-B8E8-8FD95E0B750F</gtr:id><gtr:impact>Joint publication 12121997</gtr:impact><gtr:partnerContribution>Access to a novel model system of clinical importance</gtr:partnerContribution><gtr:piContribution>Expertise in PDE4 biology. PDE4 immunological reagents</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Memory and Learning (1)</gtr:description><gtr:id>E0ECECAC-90FC-4F2E-8C0B-01D7EB1DF909</gtr:id><gtr:impact>Publications 16738544 18230676 19847264</gtr:impact><gtr:partnerContribution>Access to in vivo models</gtr:partnerContribution><gtr:piContribution>Expertise in PDE4 biology and reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Kassel</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:description>Anchored cAMP Signalling (3)</gtr:description><gtr:id>64F5B21F-306D-41B2-8670-58E6DF36DC6F</gtr:id><gtr:impact>Reagent and expertise exchange. Joint publications. Partner in listed EU grants 17088426</gtr:impact><gtr:partnerContribution>Reagent and expertise exchange. Joint publications.</gtr:partnerContribution><gtr:piContribution>Expertise in PDE4 biology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cancer Research UK (CRUK)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>The Beatson Institute for Cancer Research</gtr:department><gtr:description>PDE4 and colon cancer</gtr:description><gtr:id>307C6734-4FB7-4F53-86BB-0B360343A434</gtr:id><gtr:impact>Joint publication 15126637 17545604</gtr:impact><gtr:partnerContribution>Novel cell lines for analysis</gtr:partnerContribution><gtr:piContribution>PDE4 biology expertise and immunological reagents</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Alabama at Birmingham</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>PDE4 isoforms</gtr:description><gtr:id>CB916B1B-7FB1-4828-9C3C-4C198977D817</gtr:id><gtr:impact>Joint publications 16689683 14500724 12810716 12441002 12435793 12193273</gtr:impact><gtr:partnerContribution>Clones of a novel PDE4 isoform</gtr:partnerContribution><gtr:piContribution>Expertise in PDE4 biology and enzymology. Immunological reagents.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Padova</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Anchored cAMP Signalling (4)</gtr:description><gtr:id>A0F8A3D0-57F2-4CC0-B80C-9CAC6D7EBD38</gtr:id><gtr:impact>Joint publications 15178638 15470025 16357307</gtr:impact><gtr:partnerContribution>Access to FRET technology for assessing cAMP levels in living cells</gtr:partnerContribution><gtr:piContribution>Expertise in PDE4 Biology. Immunological reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of North Carolina</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>PDE4 Structure</gtr:description><gtr:id>315B2916-D06D-4C11-8B93-132FB1B39F68</gtr:id><gtr:impact>Joint Publication 17727341</gtr:impact><gtr:piContribution>Expertsie in PDE4 Biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Novartis</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>PDE4 isoform function</gtr:description><gtr:id>A6941F10-9E16-4CFD-9A38-E3C9EEFB47B5</gtr:id><gtr:impact>Joint publications 12023945 12121997 15025561 15905070 16030021</gtr:impact><gtr:partnerContribution>Antisera, siRNA reagents, selective PDE4 inhibitors, access to clinical samples</gtr:partnerContribution><gtr:piContribution>Expertise in PDE4 biology</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>European Molecular Biology Laboratory (EMBL)</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>EMBL Heidelberg</gtr:department><gtr:description>Macrophages</gtr:description><gtr:id>6AB6DDCA-2BBA-4E6C-A6F7-19282197DE4D</gtr:id><gtr:impact>Joint Publication 16931599</gtr:impact><gtr:partnerContribution>Access to a novel cell model</gtr:partnerContribution><gtr:piContribution>Expertise in PDE4 Biology and immunological reagents</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oslo</gtr:collaboratingOrganisation><gtr:country>Norway, Kingdom of</gtr:country><gtr:description>Anchored cAMP Signalling (1)</gtr:description><gtr:id>987C1043-B86A-4EC4-AC18-16501BAB45FC</gtr:id><gtr:impact>Reagent and expertise exchange. Joint publications. Partner in listed EU grants 15470025 15905070 16828089</gtr:impact><gtr:partnerContribution>Reagent exchange. Knowledge of immunology.</gtr:partnerContribution><gtr:piContribution>Expertise in PDE4 biology.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Heriot-Watt University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>PDE4 structure (2)</gtr:description><gtr:id>7D68D96D-62CF-436D-A246-ACA8A20D2321</gtr:id><gtr:impact>Joint publication 12444918</gtr:impact><gtr:partnerContribution>Chemistry expertise</gtr:partnerContribution><gtr:piContribution>PDE4 biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Leibniz Association</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Leibniz-Institute for Molecular Pharmacology</gtr:department><gtr:description>Anchored cAMP Signalling (2)</gtr:description><gtr:id>8969C859-D9EE-4244-847B-50E6CFC0BB3C</gtr:id><gtr:impact>Reagent and expertise exchange. Joint publications. Partner in listed EU grants 16030021 16246107 16500722 16689683 17135396 17288540 17576803</gtr:impact><gtr:partnerContribution>Reagent and expertise exchange. Joint publications. Partner in listed EU grants</gtr:partnerContribution><gtr:piContribution>Expertise in PDE4 biology.</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Memory and Learning (2)</gtr:description><gtr:id>605E4D33-AF66-4050-9269-C53D570522A2</gtr:id><gtr:impact>Joint Publications 16293762</gtr:impact><gtr:partnerContribution>Introduced us to a new scaffold system involving PDE4</gtr:partnerContribution><gtr:piContribution>Expertise in PDE4 Biology. Reagents.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visit -Renfrewshire</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8FECE9F1-D583-4527-A353-521E7B96146D</gtr:id><gtr:impact>talked to students about research in cell signalling and its biomedical importance.

hoped that this encouraged individuals on this career path. some individuals contacted me for advice.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press release - colon cancer</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>467D39A4-E327-4105-B788-2B612AF3016C</gtr:id><gtr:impact>contributed to a press release indicating that PDE4 inhibitors and adenylyl cyclase activators could form a therapeutic approach for certain types of colon cancer.

contacted by members of the public and pharmaceutical industry.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Press Release - DISC1</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1D1294B7-07FC-4F5B-8ECB-2F64725071BC</gtr:id><gtr:impact>contributed to a press release concerning the role of mutant forms of the Disc1 scaffold protein to schizophrenia.

contacted by members of the public.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>500000</gtr:amountPounds><gtr:country>France, French Republic</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Transatlantic Network of Excellence (co-PI)</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Transatlantic Networks of Excellence in Cardiovascular Research Program</gtr:fundingOrg><gtr:id>47D8B4B6-BD0B-4DB0-8A2A-42E175EE9AAC</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1900000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>EB59BF4B-C745-44DE-9D99-67A690C15249</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>58000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Capacity Building Studentship</gtr:description><gtr:end>2009-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DC634C6A-E3B7-4EF8-A82F-50913B2C9C24</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A single point mutation in the active site was first made to catalytically inactive a particular PDE4 isoform. Overexpression of this in cells would 'replace' the tethered cognate form at a particular site in a cell, thereby increasing localized cAMP levels around this specific site, with a defined phenotypic output. This, effectively, inhibits a specific isoform at a specific site.</gtr:description><gtr:id>3BEB7BE6-AB8D-4145-964E-364B39BE05F5</gtr:id><gtr:impact>We used these novel reagents to great effect in altering people's perception of the functioning of PDE4 isoforms by showing that (i) the tethering of specific isoforms was critical to phenotypic function and that (ii) isoforms had non-redundant roles in cells that depended upon their targeting. Provides proof of principal of a novel therapeutic approach based upon displacing specific PDE4 isoforms from specific sites in cells with much reduced side effects. Extremely beneficial collaborations resulted from sharing these that have greatly aided our research.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Dominant Negative PDE4 constructs</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Antisera specific for each of the four PDE4 sub-families</gtr:description><gtr:id>BBBBB543-8D27-4CDF-9DDD-193AC501F82F</gtr:id><gtr:impact>Extremely beneficial collaborations that have greatly aided our research.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PDE4 antisera</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>at the very start of siRNA being developed we generated reagents to knock down specific sub-families.</gtr:description><gtr:id>C58BF2A6-6DC7-4084-B0DB-EFECC799B564</gtr:id><gtr:impact>We used these novel reagents to great effect in altering people's perception of the functioning of PDE4 subfamilies by showing that they had non-redundant roles in cells. Extremely beneficial collaborations that have greatly aided our research.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>siRNA for PDE4 sub-families</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/08E842F5-DC21-418C-906B-85FF8EFDE015"><gtr:id>08E842F5-DC21-418C-906B-85FF8EFDE015</gtr:id><gtr:title>In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region.</gtr:title><gtr:parentPublicationTitle>Cellular signalling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c640a488ed782ca29167e2dde18f664b"><gtr:id>c640a488ed782ca29167e2dde18f664b</gtr:id><gtr:otherNames>McCahill A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0898-6568</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B414E89E-6B0C-4821-8D1C-980D437183C2"><gtr:id>B414E89E-6B0C-4821-8D1C-980D437183C2</gtr:id><gtr:title>Human PDE4A8, a novel brain-expressed PDE4 cAMP-specific phosphodiesterase that has undergone rapid evolutionary change.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c922c509d07d982116722e1f090ea640"><gtr:id>c922c509d07d982116722e1f090ea640</gtr:id><gtr:otherNames>Mackenzie KF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/64C97ADA-5DC5-4E0A-8880-3AC1B965803A"><gtr:id>64C97ADA-5DC5-4E0A-8880-3AC1B965803A</gtr:id><gtr:title>Keynote review: phosphodiesterase-4 as a therapeutic target.</gtr:title><gtr:parentPublicationTitle>Drug discovery today</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0e56f4d61095980aaabb017d2aa7616e"><gtr:id>0e56f4d61095980aaabb017d2aa7616e</gtr:id><gtr:otherNames>Houslay MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1359-6446</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C2A63915-DF0D-46B1-80BE-F1F0252583CA"><gtr:id>C2A63915-DF0D-46B1-80BE-F1F0252583CA</gtr:id><gtr:title>EPAC and PKA allow cAMP dual control over DNA-PK nuclear translocation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ecf4cd9acb13c24315858961d0ffcd3d"><gtr:id>ecf4cd9acb13c24315858961d0ffcd3d</gtr:id><gtr:otherNames>Huston E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A71CCBBF-EDD2-49AD-8DD0-49F92CC9CB76"><gtr:id>A71CCBBF-EDD2-49AD-8DD0-49F92CC9CB76</gtr:id><gtr:title>cAMP phosphodiesterase-4A1 (PDE4A1) has provided the paradigm for the intracellular targeting of phosphodiesterases, a process that underpins compartmentalized cAMP signalling.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ecf4cd9acb13c24315858961d0ffcd3d"><gtr:id>ecf4cd9acb13c24315858961d0ffcd3d</gtr:id><gtr:otherNames>Huston E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/30082198-232C-4271-AF71-C09592909605"><gtr:id>30082198-232C-4271-AF71-C09592909605</gtr:id><gtr:title>The dg2 (for) gene confers a renal phenotype in Drosophila by modulation of cGMP-specific phosphodiesterase.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d316191e0075084490840c1918f82bd7"><gtr:id>d316191e0075084490840c1918f82bd7</gtr:id><gtr:otherNames>MacPherson MR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-0949</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2C1DB140-B2AB-4023-A2E0-C20D437D8F26"><gtr:id>2C1DB140-B2AB-4023-A2E0-C20D437D8F26</gtr:id><gtr:title>Cyclic nucleotide phosphodiesterases in Drosophila melanogaster.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d46a299510bcbef6c0115bee738cd56"><gtr:id>7d46a299510bcbef6c0115bee738cd56</gtr:id><gtr:otherNames>Day JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3E93EC27-C51F-460B-B069-204DCA1E8746"><gtr:id>3E93EC27-C51F-460B-B069-204DCA1E8746</gtr:id><gtr:title>Constitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP.</gtr:title><gtr:parentPublicationTitle>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d68d9d60dc03e9488b19d262c79dce20"><gtr:id>d68d9d60dc03e9488b19d262c79dce20</gtr:id><gtr:otherNames>Kelly MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0893-133X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/93E822D1-1301-4961-9BCD-647D81DFEBB5"><gtr:id>93E822D1-1301-4961-9BCD-647D81DFEBB5</gtr:id><gtr:title>Hypoxia-induced remodelling of PDE4 isoform expression and cAMP handling in human pulmonary artery smooth muscle cells.</gtr:title><gtr:parentPublicationTitle>European journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ec52edf1b1433830c42cfe40167ca79e"><gtr:id>ec52edf1b1433830c42cfe40167ca79e</gtr:id><gtr:otherNames>Millen J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0171-9335</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40545101-FC0D-43A0-BC82-08DE47088B44"><gtr:id>40545101-FC0D-43A0-BC82-08DE47088B44</gtr:id><gtr:title>TCR- and CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ccc81ee5ccd610f04d3e621c309a4110"><gtr:id>ccc81ee5ccd610f04d3e621c309a4110</gtr:id><gtr:otherNames>Abrahamsen H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D23F9430-14A0-4290-B7AA-8F262F701D08"><gtr:id>D23F9430-14A0-4290-B7AA-8F262F701D08</gtr:id><gtr:title>Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9946144ae62da37ee90f7ccd99565e9f"><gtr:id>9946144ae62da37ee90f7ccd99565e9f</gtr:id><gtr:otherNames>McEwan DG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/49E0FC82-9B1F-463C-8223-0DC5954C9B7A"><gtr:id>49E0FC82-9B1F-463C-8223-0DC5954C9B7A</gtr:id><gtr:title>A novel role for a Drosophila homologue of cGMP-specific phosphodiesterase in the active transport of cGMP.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d46a299510bcbef6c0115bee738cd56"><gtr:id>7d46a299510bcbef6c0115bee738cd56</gtr:id><gtr:otherNames>Day JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2643784A-5970-4476-9C4C-D4ED3D991189"><gtr:id>2643784A-5970-4476-9C4C-D4ED3D991189</gtr:id><gtr:title>Scanning peptide array analyses identify overlapping binding sites for the signalling scaffold proteins, beta-arrestin and RACK1, in cAMP-specific phosphodiesterase PDE4D5.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aad052ec78f936293fddb51160ecfed0"><gtr:id>aad052ec78f936293fddb51160ecfed0</gtr:id><gtr:otherNames>Bolger GB</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F0B47E06-58FF-40D5-82DB-0E09F4F6033F"><gtr:id>F0B47E06-58FF-40D5-82DB-0E09F4F6033F</gtr:id><gtr:title>Identification and characterization of PDE4A11, a novel, widely expressed long isoform encoded by the human PDE4A cAMP phosphodiesterase gene.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/418da1af48b8b0b53c2edb1279c6a9b0"><gtr:id>418da1af48b8b0b53c2edb1279c6a9b0</gtr:id><gtr:otherNames>Wallace DA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/583A62F3-2B73-4250-915B-744E46286A57"><gtr:id>583A62F3-2B73-4250-915B-744E46286A57</gtr:id><gtr:title>Beta-arrestin-recruited phosphodiesterase-4 desensitizes the AKAP79/PKA-mediated switching of beta2-adrenoceptor signalling to activation of ERK.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0e56f4d61095980aaabb017d2aa7616e"><gtr:id>0e56f4d61095980aaabb017d2aa7616e</gtr:id><gtr:otherNames>Houslay MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B3011516-6E06-4134-92F5-C56E29CFE48E"><gtr:id>B3011516-6E06-4134-92F5-C56E29CFE48E</gtr:id><gtr:title>Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes.</gtr:title><gtr:parentPublicationTitle>Current opinion in cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/68e131f4e73386b42f4a019c05ee6cea"><gtr:id>68e131f4e73386b42f4a019c05ee6cea</gtr:id><gtr:otherNames>Baillie GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0955-0674</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8E1A2710-6D88-4714-9B17-7B48F545B597"><gtr:id>8E1A2710-6D88-4714-9B17-7B48F545B597</gtr:id><gtr:title>Tyrosine 302 in RACK1 is essential for insulin-like growth factor-I-mediated competitive binding of PP2A and beta1 integrin and for tumor cell proliferation and migration.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/771a782eab14f8ce2ca63859a833bd41"><gtr:id>771a782eab14f8ce2ca63859a833bd41</gtr:id><gtr:otherNames>Kiely PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6EA790BD-24E3-4965-BBCF-59292C06E225"><gtr:id>6EA790BD-24E3-4965-BBCF-59292C06E225</gtr:id><gtr:title>The long and short of vascular smooth muscle phosphodiesterase-4 as a putative therapeutic target.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0e56f4d61095980aaabb017d2aa7616e"><gtr:id>0e56f4d61095980aaabb017d2aa7616e</gtr:id><gtr:otherNames>Houslay MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40A05E8B-6A33-4CA7-AF80-9F0E4E0BD6F9"><gtr:id>40A05E8B-6A33-4CA7-AF80-9F0E4E0BD6F9</gtr:id><gtr:title>Spatial organisation of AKAP18 and PDE4 isoforms in renal collecting duct principal cells.</gtr:title><gtr:parentPublicationTitle>European journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4f375ac0696a7ca6f99958177d324a79"><gtr:id>4f375ac0696a7ca6f99958177d324a79</gtr:id><gtr:otherNames>McSorley T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0171-9335</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A9614FFA-6E79-42BC-8E6A-AC77B4EB921F"><gtr:id>A9614FFA-6E79-42BC-8E6A-AC77B4EB921F</gtr:id><gtr:title>Differential expression of PDE4 cAMP phosphodiesterase isoforms in inflammatory cells of smokers with COPD, smokers without COPD, and nonsmokers.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Lung cellular and molecular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/cdb522ff506c574784a596579795e3de"><gtr:id>cdb522ff506c574784a596579795e3de</gtr:id><gtr:otherNames>Barber R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>1040-0605</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5ACC5A5F-1A3F-439D-8F76-404E00D7D1D8"><gtr:id>5ACC5A5F-1A3F-439D-8F76-404E00D7D1D8</gtr:id><gtr:title>RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta2-adrenergic receptor to activation of ERK in HEK293B2 cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/676166fcb358e638222e71174647935b"><gtr:id>676166fcb358e638222e71174647935b</gtr:id><gtr:otherNames>Lynch MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2ED111FB-BE90-4802-8CFB-CE099A837E62"><gtr:id>2ED111FB-BE90-4802-8CFB-CE099A837E62</gtr:id><gtr:title>PDE4 associates with different scaffolding proteins: modulating interactions as treatment for certain diseases.</gtr:title><gtr:parentPublicationTitle>Handbook of experimental pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0c04fe0beea4e97f9253297a2a02b423"><gtr:id>0c04fe0beea4e97f9253297a2a02b423</gtr:id><gtr:otherNames>McCahill AC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0171-2004</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1480C140-D901-4ED7-9743-EC073846D106"><gtr:id>1480C140-D901-4ED7-9743-EC073846D106</gtr:id><gtr:title>DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0d3286e7a6e404467d83d9f5c7828d1c"><gtr:id>0d3286e7a6e404467d83d9f5c7828d1c</gtr:id><gtr:otherNames>Millar JK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/90EECF09-1AE7-45F7-B304-0513648E82E3"><gtr:id>90EECF09-1AE7-45F7-B304-0513648E82E3</gtr:id><gtr:title>Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d604497e66a66d3eb02a57da1a75144"><gtr:id>2d604497e66a66d3eb02a57da1a75144</gtr:id><gtr:otherNames>Mongillo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AFCF083F-2D95-4F75-9710-C177079DDC6F"><gtr:id>AFCF083F-2D95-4F75-9710-C177079DDC6F</gtr:id><gtr:title>Compartmentalized phosphodiesterase-2 activity blunts beta-adrenergic cardiac inotropy via an NO/cGMP-dependent pathway.</gtr:title><gtr:parentPublicationTitle>Circulation research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2d604497e66a66d3eb02a57da1a75144"><gtr:id>2d604497e66a66d3eb02a57da1a75144</gtr:id><gtr:otherNames>Mongillo M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0009-7330</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7BD5BF3C-BF02-496D-B36F-DB3520394F71"><gtr:id>7BD5BF3C-BF02-496D-B36F-DB3520394F71</gtr:id><gtr:title>Compartmentalized cAMP signalling regulates vasopressin-mediated water reabsorption by controlling aquaporin-2.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/956e7e09bb545146399f98077f9a379c"><gtr:id>956e7e09bb545146399f98077f9a379c</gtr:id><gtr:otherNames>Henn V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2DC11A89-32B7-4F00-B769-F0E14FB84BA3"><gtr:id>2DC11A89-32B7-4F00-B769-F0E14FB84BA3</gtr:id><gtr:title>Compartmentalization of cAMP-dependent signaling by phosphodiesterase-4D is involved in the regulation of vasopressin-mediated water reabsorption in renal principal cells.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a9e03506f0a33464d46e1efd22a8a009"><gtr:id>a9e03506f0a33464d46e1efd22a8a009</gtr:id><gtr:otherNames>Stefan E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/248DFB70-7E01-4F32-8328-4FF27A6D27F3"><gtr:id>248DFB70-7E01-4F32-8328-4FF27A6D27F3</gtr:id><gtr:title>Regulation of a Drosophila melanogaster cGMP-specific phosphodiesterase by prenylation and interaction with a prenyl-binding protein.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7d46a299510bcbef6c0115bee738cd56"><gtr:id>7d46a299510bcbef6c0115bee738cd56</gtr:id><gtr:otherNames>Day JP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5C7AD22C-A63F-4789-A462-E6F14FEB91CE"><gtr:id>5C7AD22C-A63F-4789-A462-E6F14FEB91CE</gtr:id><gtr:title>cAMP synthesis and degradation by phagosomes regulate actin assembly and fusion events: consequences for mycobacteria.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/65429361209d07c65209e8041079e919"><gtr:id>65429361209d07c65209e8041079e919</gtr:id><gtr:otherNames>Kalamidas SA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2B642B49-DE4B-49BD-B820-E61FE8716878"><gtr:id>2B642B49-DE4B-49BD-B820-E61FE8716878</gtr:id><gtr:title>Oxidative stress employs phosphatidyl inositol 3-kinase and ERK signalling pathways to activate cAMP phosphodiesterase-4D3 (PDE4D3) through multi-site phosphorylation at Ser239 and Ser579.</gtr:title><gtr:parentPublicationTitle>Cellular signalling</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a3e004cc844ce04d682be3b3d3291685"><gtr:id>a3e004cc844ce04d682be3b3d3291685</gtr:id><gtr:otherNames>Hill EV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0898-6568</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1D934127-93A7-42F1-8597-CE8239373446"><gtr:id>1D934127-93A7-42F1-8597-CE8239373446</gtr:id><gtr:title>Constitutive activation of the G-protein subunit Galphas within forebrain neurons causes PKA-dependent alterations in fear conditioning and cortical Arc mRNA expression.</gtr:title><gtr:parentPublicationTitle>Learning &amp; memory (Cold Spring Harbor, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d68d9d60dc03e9488b19d262c79dce20"><gtr:id>d68d9d60dc03e9488b19d262c79dce20</gtr:id><gtr:otherNames>Kelly MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1072-0502</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/15832E88-BF2C-4A7E-A640-33F4156C1FA5"><gtr:id>15832E88-BF2C-4A7E-A640-33F4156C1FA5</gtr:id><gtr:title>Helix-1 of the cAMP-specific phosphodiesterase PDE4A1 regulates its phospholipase-D-dependent redistribution in response to release of Ca2+.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ecf4cd9acb13c24315858961d0ffcd3d"><gtr:id>ecf4cd9acb13c24315858961d0ffcd3d</gtr:id><gtr:otherNames>Huston E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/27EA9F72-7607-444B-A9DE-0C8C00401FDD"><gtr:id>27EA9F72-7607-444B-A9DE-0C8C00401FDD</gtr:id><gtr:title>Expression, intracellular distribution and basis for lack of catalytic activity of the PDE4A7 isoform encoded by the human PDE4A cAMP-specific phosphodiesterase gene.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/60b8c18cfb07d9e4cb46bcb7b5fc9c2c"><gtr:id>60b8c18cfb07d9e4cb46bcb7b5fc9c2c</gtr:id><gtr:otherNames>Johnston LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1A4ECDF7-C623-44E3-B9DA-8114068220C6"><gtr:id>1A4ECDF7-C623-44E3-B9DA-8114068220C6</gtr:id><gtr:title>MEK1 binds directly to betaarrestin1, influencing both its phosphorylation by ERK and the timing of its isoprenaline-stimulated internalization.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9b0457324b4db06708dfba291ef09e54"><gtr:id>9b0457324b4db06708dfba291ef09e54</gtr:id><gtr:otherNames>Meng D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7D263EB1-0A3B-41DD-9B23-84006442374B"><gtr:id>7D263EB1-0A3B-41DD-9B23-84006442374B</gtr:id><gtr:title>A RSK(y) relationship with promiscuous PKA.</gtr:title><gtr:parentPublicationTitle>Science's STKE : signal transduction knowledge environment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0e56f4d61095980aaabb017d2aa7616e"><gtr:id>0e56f4d61095980aaabb017d2aa7616e</gtr:id><gtr:otherNames>Houslay MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1525-8882</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/1BD3A1B3-BE4C-43ED-A81A-811D0A322D43"><gtr:id>1BD3A1B3-BE4C-43ED-A81A-811D0A322D43</gtr:id><gtr:title>Remodelling of the PDE4 cAMP phosphodiesterase isoform profile upon monocyte-macrophage differentiation of human U937 cells.</gtr:title><gtr:parentPublicationTitle>British journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7095107c24f036477be50f3a8b26acc3"><gtr:id>7095107c24f036477be50f3a8b26acc3</gtr:id><gtr:otherNames>Shepherd MC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0007-1188</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D24EE1E1-6B27-4BBE-B45A-22D8C1DA3BCE"><gtr:id>D24EE1E1-6B27-4BBE-B45A-22D8C1DA3BCE</gtr:id><gtr:title>Phosphodiesterase-4 gates the ability of protein kinase A to phosphorylate G-protein receptor kinase-2 and influence its translocation.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0e56f4d61095980aaabb017d2aa7616e"><gtr:id>0e56f4d61095980aaabb017d2aa7616e</gtr:id><gtr:otherNames>Houslay MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E4C10E30-1526-4FE0-8687-7A4A7DA35BF1"><gtr:id>E4C10E30-1526-4FE0-8687-7A4A7DA35BF1</gtr:id><gtr:title>PDE4-regulated cAMP degradation controls the assembly of integrin-dependent actin adhesion structures and REF52 cell migration.</gtr:title><gtr:parentPublicationTitle>Journal of cell science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f0111ca26f6af64ba8646a4897d56581"><gtr:id>f0111ca26f6af64ba8646a4897d56581</gtr:id><gtr:otherNames>Fleming YM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2004-01-01</gtr:date><gtr:issn>0021-9533</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5E7B7684-79CD-486C-96C7-5F84028DEA25"><gtr:id>5E7B7684-79CD-486C-96C7-5F84028DEA25</gtr:id><gtr:title>PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases.</gtr:title><gtr:parentPublicationTitle>The Journal of cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7afc7f7113429e528794e559d52e7889"><gtr:id>7afc7f7113429e528794e559d52e7889</gtr:id><gtr:otherNames>Terrin A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9525</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7F30A4F3-A811-4859-8D52-EADC9415C08C"><gtr:id>7F30A4F3-A811-4859-8D52-EADC9415C08C</gtr:id><gtr:title>Compartmentalisation of phosphodiesterases and protein kinase A: opposites attract.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/68e131f4e73386b42f4a019c05ee6cea"><gtr:id>68e131f4e73386b42f4a019c05ee6cea</gtr:id><gtr:otherNames>Baillie GS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/40B77765-0A51-4E5D-AE65-6B5D5343F667"><gtr:id>40B77765-0A51-4E5D-AE65-6B5D5343F667</gtr:id><gtr:title>Investigation of extracellular signal-regulated kinase 2 mitogen-activated protein kinase phosphorylation and regulation of activity of PDE4 cyclic adenosine monophosphate-specific phosphodiesterases.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a3e004cc844ce04d682be3b3d3291685"><gtr:id>a3e004cc844ce04d682be3b3d3291685</gtr:id><gtr:otherNames>Hill EV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2005-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C1DF94BD-7F21-4BEC-9C4C-53DFEC7491A0"><gtr:id>C1DF94BD-7F21-4BEC-9C4C-53DFEC7491A0</gtr:id><gtr:title>Reduced PDE4 expression and activity contributes to enhanced catecholamine-induced cAMP accumulation in adipocytes from FOXC2 transgenic mice.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/325b9582b10806a6dfec32ac07ab0113"><gtr:id>325b9582b10806a6dfec32ac07ab0113</gtr:id><gtr:otherNames>Gr?nning LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A21AE1CF-D163-4B9E-84C1-5FBE3CA8284A"><gtr:id>A21AE1CF-D163-4B9E-84C1-5FBE3CA8284A</gtr:id><gtr:title>Phosphodiesterase-4 influences the PKA phosphorylation status and membrane translocation of G-protein receptor kinase 2 (GRK2) in HEK-293beta2 cells and cardiac myocytes.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/93f8556619f3487d06c35513ec7d86fb"><gtr:id>93f8556619f3487d06c35513ec7d86fb</gtr:id><gtr:otherNames>Li X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0CAD0A85-9091-4BB8-B8F3-F813E1826C8C"><gtr:id>0CAD0A85-9091-4BB8-B8F3-F813E1826C8C</gtr:id><gtr:title>Intracellular targeting of phosphodiesterase-4 underpins compartmentalized cAMP signaling.</gtr:title><gtr:parentPublicationTitle>Current topics in developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/676166fcb358e638222e71174647935b"><gtr:id>676166fcb358e638222e71174647935b</gtr:id><gtr:otherNames>Lynch MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0070-2153</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G8604010</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>